Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Carolina García‐Vidal, Alberto Cózar-Llistó, Fernanda Salazar Meira, Gerard Dueñas, Pedro Puerta‐Alcalde, Catia Cilloniz, Nicole García-Pouton, Mariana Chumbita, Celia Cardozo, Verónica Rico, Marta Bodro, Laura Morata, Pedro Castro, Alex Almuedo-Riera, Felipe García, Josep Mensa, José Antonio Martínez, Gemma Sanjuan, Antoní Torres, JM Nicolás, Àlex Soriano
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
10.1016/s0140-6736(20)31189-2 · 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
10.1016/s0140-6736(20)30566-3 · 2020
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
10.1016/j.cmi.2020.07.024 · 2020
Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: initial report of the international RISC-19-ICU prospective observational cohort
10.1016/j.eclinm.2020.100449 · 2020
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
10.1016/s2213-2600(20)30079-5 · 2020
Personalized therapy approach for hospitalized patients with COVID-19
2020
Remdesivir for the treatment of Covid-19 – final report
10.1056/nejmoa2007764 · 2020
Dexamethasone in hospitalized patients with Covid-19 – preliminary report
2020
Artificial intelligence to support clinical decision-making processes
10.1016/j.ebiom.2019.07.019 · 2019
The natural history and transmission potential of asymptomatic severe acute respiratory syndrome coronavirus 2 infection
10.1093/cid/ciaa711 · 2020
Trends in COVID-19 risk-adjusted mortality rates
2020
Declines in mortality over time for critically ill adults with Coronavirus disease 2019
10.1097/ccm.0000000000004687 · 2020
Improving survival of critical care patients with coronavirus disease 2019 in England
2020
Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area
10.1001/jama.2020.6775 · 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
10.1016/s0140-6736(20)31757-8 · 2020
Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
10.1016/j.cell.2020.06.043 · 2020
Factors associated with COVID-19-related death using OpenSAFELY
10.1038/s41586-020-2521-4 · 2020
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19
2020
Efficacy of tocilizumab in patients hospitalized with Covid-19
10.1056/nejmoa2028836 · 2020
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial
2020
Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial
2020
No additional external references are available.